Search
for
Sort by
Research 121–150 of 1000+
- Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer
- 202 Activation of breast cancer cell proliferation by ROR-alpha through aromatase promoter
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- Epidermal abnormalities and increased malignancy of skin tumors in human epidermal keratin 8‐expressing transgenic mice
- Alopecia neoplastica simulating alopecia areata and antedating the detection of primary breast carcinoma
- Ovarian Leydig cell tumor and postmenopausal hirsutism with signs of virilisation
- Antitumor Activities of the Typhonium flagelliforme Extract Combined with Natural Interferons of Canine and Feline in Mice with DMBA Induced Skin Tumors
- Hétérogénéité tumorale du cancer de la prostate et infection par le SARS-CoV2 : une relation complexe impliquant les vésicules extracellulaires et le récepteur des androgènes
- Aromatase inhibitor therapy and hair loss among breast cancer survivors
- Real-World Safety Profile of Generic Palbociclib in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Prospective Observational Study in Iraq”
- 5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis
- First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study
- FEMALE BREAST CANCER PROTECTION USING PHYTOESTROGEN LIGNANS FROM FLAXSEED
- Immune Microenvironment of Hair Follicles in Tumor Immunotherapy
- Androgen Secreting Steroid Cell Tumor of the Ovary Represented with Postmenopasal Bleeding and Extensive Hirsutism
- Finasteride treatment and male breast cancer: a register-based cohort study in four Nordic countries
- Challenges in diagnosing ovarian sertoli-leydig cell tumors: A Peruvian case series
- ANALYSIS OF ADVERSE DRUG REACTIONS (ADRs) AND THEIR SEVERITY IN BREAST CANCER PATIENTS TREATED WITH THE DOCETAXEL-DOXORUBICIN REGIMEN AT SULTAN AGUNG ISLAMIC HOSPITAL
- Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer
- Hair shaft miRNA‐221 levels as a new tumor marker of malignant melanoma
- Original synthetic monophenolic antioxidant with combined effect inhibits tumor growth in vivo
- Ayurveda-Based Supportive Care Using Guduchi, Ashwagandha, and Curcumin for Breast Cancer Patients: A Pilot Observational Study on Quality of Life and Safety
- Alopecia induced by CDK 4/6 Inhibitors and its Impact on the Quality of Life of Patients with advanced Breast cancer
- Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody–drug conjugate in breast cancer
- Selenium or No Selenium- That Is the Question in Tumor Patients: A New Controversy
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis
- Scalp hypothermia for the prevention of chemotherapy-induced alopecia in breast cancer
- RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER